Important: This page is for informational purposes only, based on published peer-reviewed research and official UK dietary guidelines (NHS, EFSA, SACN). It does not constitute medical advice. Always consult your GP or pharmacist before starting, stopping, or combining supplements.
Calcium and Vitamin K2 — Can You Take Them Together?
Overview
Calcium and Vitamin K2 are increasingly recognised as a complementary pairing in bone and cardiovascular health research. Whilst calcium is essential for bone mineralisation — with SACN recommending 700 mg per day for UK adults — studies suggest that supplemental calcium without adequate K2 may not reach its intended destination. Vitamin K2 activates proteins that govern where calcium is deposited in the body, directing it towards bone and away from soft tissues such as arterial walls. Individual responses may vary, but the emerging evidence points towards the value of considering these two nutrients in conjunction rather than in isolation.
How They Interact
Vitamin K2 functions as an essential cofactor for the enzyme gamma-glutamyl carboxylase, which carboxylates — and thereby activates — two critical calcium-regulating proteins. The first is osteocalcin, synthesised by osteoblasts; once carboxylated, it binds calcium ions and anchors them within the bone matrix. In states of Vitamin K2 insufficiency, osteocalcin remains undercarboxylated and loses its affinity for calcium, reducing mineralisation. The second protein, matrix GLA protein (MGP), is expressed in vascular smooth muscle cells and acts as the body's primary inhibitor of arterial calcification. Schurgers et al. (2008, Thromb Haemost, PMID 18841280) demonstrated that MGP requires vitamin K-dependent carboxylation to become biologically active; undercarboxylated MGP accumulates in calcified atherosclerotic plaques and is associated with vascular calcification. This dual mechanism — promoting bone uptake whilst simultaneously inhibiting ectopic calcium deposition in arterial walls — explains the growing scientific interest in pairing these two nutrients. The Rotterdam Study (Geleijnse et al., 2004, J Nutr, PMID 15514282) found higher dietary menaquinone intake associated with reduced coronary heart disease mortality, consistent with MGP-mediated vascular protection.
Timing & Dosage Guidance
Both calcium and Vitamin K2 are best absorbed when taken with food, particularly a meal containing some dietary fat. Vitamin K2 in MK-7 form is fat-soluble and relies on bile-mediated fat digestion for absorption. Calcium carbonate specifically requires stomach acid to dissociate and is most effective taken with meals; calcium citrate can be taken with or without food. There is no known pharmacokinetic conflict between the two nutrients when taken simultaneously. Splitting calcium supplementation into doses of 500 mg or less across the day may improve absorption compared with a single large dose, and Vitamin K2 can be taken alongside any one of these calcium doses.
The UK SACN reference nutrient intake for calcium is 700 mg per day for adults, with most dietary surveys indicating that many UK adults fall below this through diet alone. Supplemental calcium doses in studies and clinical guidance typically range from 500–1,000 mg per day. EFSA has approved a health claim linking calcium to normal bone maintenance (Regulation EC No 1924/2006). For Vitamin K2, EFSA sets an adequate intake for total Vitamin K at 70 mcg per day; clinical bone studies have used MK-7 at 90–200 mcg per day. There is no established tolerable upper intake level for Vitamin K2 from food sources. However, individuals taking anticoagulant medication such as warfarin should consult their GP before supplementing, as Vitamin K directly influences clotting factor activity.
Recommended Action
Adding Vitamin K2 when supplementing calcium is increasingly recommended in the literature to support proper calcium utilisation.
Calcium Timing
When: Any
Note: Carbonate requires stomach acid — take with food. Citrate can be taken on empty stomach. Split doses of >500 mg for better absorption.
Vitamin K2 Timing
When: Morning
Note: Fat-soluble — take with a meal containing dietary fat
Scientific Evidence
4 peer-reviewed studies cited. All links lead to PubMed abstracts.
Journal of Nutrition (2004) · PMID: 15514282
Higher dietary menaquinone (K2) intake was associated with significantly reduced coronary heart disease mortality and aortic calcification in a prospective cohort of 4,807 Dutch adults followed for approximately seven years.
Osteoporosis International (2013) · PMID: 23525894
MK-7 supplementation at 180 mcg per day over three years significantly reduced age-related declines in bone mineral density at the lumbar spine and femoral neck, and decreased vertebral height loss in postmenopausal women.
Thrombosis and Haemostasis (2008) · PMID: 18841280
MGP requires vitamin K-dependent carboxylation to inhibit arterial calcification; undercarboxylated MGP accumulates in calcified vascular plaques, directly implicating K2 insufficiency in ectopic soft-tissue calcium deposition.
BMJ (2010) · PMID: 20671013
Calcium supplementation without co-administered vitamin D was associated with a 27–31% increased relative risk of myocardial infarction across 15 trials, providing a clinical rationale for co-supplementation with Vitamin K2 to support appropriate calcium routing.
Frequently Asked Questions
Dietary calcium is associated with fewer cardiovascular concerns than supplemental calcium, as indicated by Bolland et al. (2010, BMJ, PMID 20671013), whose meta-analysis found calcium supplements without co-administered vitamin D were linked to an elevated relative risk of myocardial infarction. Meeting the SACN-recommended 700 mg per day through food sources such as dairy, fortified plant milks, and green leafy vegetables carries a different risk profile to supplementation. Individuals who do supplement with calcium may benefit from reviewing their K2 status, though individual responses may vary.
MK-7 (menaquinone-7) is generally favoured in research settings due to its longer plasma half-life of approximately three days, compared with a matter of hours for MK-4, resulting in more sustained tissue saturation at lower doses. Knapen et al. (2013, Osteoporos Int, PMID 23525894) demonstrated significant reductions in age-related bone loss in postmenopausal women using MK-7 at 180 mcg per day over three years. MK-4 is used at substantially higher doses (typically 45 mg) in some Japanese clinical protocols. Both forms activate osteocalcin and MGP through carboxylation.
Vitamin K2 can reduce the anticoagulant efficacy of warfarin and other vitamin K antagonists, which function by blocking vitamin K-dependent activation of clotting factors. Individuals prescribed warfarin should not begin Vitamin K2 supplementation without first consulting their GP or anticoagulation clinic, as INR monitoring and dose adjustment may be required. Vitamin K2 does not appear to interact with commonly used medications beyond this class. As with any supplement, those managing diagnosed conditions or taking prescription drugs should seek professional advice before use.
Top Calcium Products on AIScored
Top Vitamin K2 Products on AIScored
Want to check more interactions?
Add these and other supplements to our interactive Stack Analyzer for a full analysis.
Build your full stack →